No black box warning on record for Trodelvy
As of the latest FDA labeling reviewed, Trodelvy (SACITUZUMAB GOVITECAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Trodelvy medicine page for the complete safety profile.